NCT06347562View on ClinicalTrials.gov

Optical Genome Mapping for the Diagnosis of Neurodevelopmental Disorders

NARecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

June 14, 2025

Study Completion Date

June 14, 2025

Conditions
Neurodevelopmental Disorder (Diagnosis)
Interventions
GENETIC

Optical Genome Mapping

to evaluate the capability of OGM, its usefulness in clinical diagnosis, and its impact on genetic counseling.

Trial Locations (1)

23842

RECRUITING

Scientific Institute E. Medea, Bosisio Parini

All Listed Sponsors
lead

IRCCS Eugenio Medea

OTHER